Cited by 121Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Expression of intercellular adhesion molecule 1 (ICAM-1) in Alzheimer’s disease

Frohman, Elliot M., Frohman, Teresa C., Gupta, Sudhir, de Fougerolles, Antonin, van den Noort, Stanley·1991·Journal of the Neurological Sciences

Abstract

In this study, 13 clinically and pathologically diagnosed cases of Alzheimer's disease were analyzed for the presence of intercellular adhesion molecule 1 (ICAM-1), ICAM-2, lymphocyte function associated antigen-1 (LFA-1), HLA-DR, LN-1, and LN-2. ICAM-1 was observed primarily on neuritic plaques and cerebrovascular endothelium. ICAM-1 was also shown to be present in brain tissue derived from 14 normal cases; however, the degree of immunoreactivity was quantitatively less compared to Alzheimer cases and was largely restricted to cerebrovascular endothelium. LFA-1 was shown to be present on microglial cells and leukocytes. Consistent with the findings of previous reports, HLA-DR was found to be expressed on microglial cells. In this study we failed to demonstrate dual immunolocalization for ICAM-1 and LFA-1, ICAM-1 and HLA-DR, or ICAM-1 and LN-2. As microglial cells express both HLA-DR and LFA-1, they may serve to mediate antigen presentation functions by interacting with lymphocyte ICAM-1. Alternately, the expression of these immune-associated glycoproteins on glial cells may be epiphenomenal occurring secondary to some aspect of the disease process. Finally, the presence of ICAM-1 within neuritic plaques raises the question as to whether adhesion may play some role in the process of neurite outgrowth and neurodegeneration.

Integrity signals

Registry

Crossref · 10.1016/0022-510x(91)90202-i

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • ICAM-1 is highly expressed in endothelial cells of AD patients.

    “However, the intercellular adhesion molecule-1 (ICAM-1) was shown to be highly expressed in endothelial cells of AD patients.486”

    From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [486]

  • ICAM-1, a biomarker of endothelial dysfunction, is increased in Alzheimer's disease, and endothelial cells, astrocytes and microglia show enhanced levels of ICAM-1 in pathological states.

    “Experimental evidence confirmed that biomarkers of endothelial dysfunction, such as intercellular adhesion molecule 1 (ICAM-1), are increased in AD; endothelial cells, astrocytes and microglia show enhanced levels of ICAM-1 in pathological states”

    From Beneficial Effects of Spirulina Consumption on Brain Health (2022) · cites this paper as [146]

  • ICAM-1 plays a role in neuritic plaques on neurite growth and neurodegeneration.

    “and this plays a role in neuritic plaques on neurite growth and neurodegeneration [145,146,147].”

    From Beneficial Effects of Spirulina Consumption on Brain Health (2022) · cites this paper as [146]

Cites

Flagged first, then by citations

1 of the 18 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Frohman, E. M., Frohman, T. C., Gupta, S., de Fougerolles, A., & van den Noort, S.
Affiliations
University of California, Irvine (US)
Corresponding author
Frohman, Elliot M.
Venue
Journal of the Neurological Sciences
Publisher
Elsevier BV
Published
1991-11
Volume
106
Issue
1
Pages
105-111
ISSN
0022-510X (ISSN-L)
OpenAlex
W1968283018
Cited by
120
References
18
Citations by year
2025: 2 · 2024: 6 · 2023: 5 · 2022: 2 · 2021: 4 · 2020: 4 · 2019: 6 · 2018: 2 · 2017: 3 · 2016: 3 · 2015: 3 · 2014: 4 · 2013: 4 · 2012: 3
FWCI
1.64
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of the Neurological Sciences (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute on Aging (AG 00538)
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
ICAM-1, Alzheimer's disease, ICAM-2, LFA-1, HLA-DR, neuritic plaques, cerebrovascular endothelium, microglial cells, leukocytes, antigen presentation, glial cells, neurodegeneration, neurite outgrowth
MeSH terms
Alzheimer Disease, Cerebral Arteries, Endothelium, Vascular, HLA-DR Antigens, Humans, Macrophages, Nerve Tissue Proteins, Neuroglia, Biomarkers, Antigens, CD, Cell Adhesion Molecules, Lymphocyte Function-Associated Antigen-1, Intercellular Adhesion Molecule-1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review